3 results
Approved WMOCompleted
To determine the effect of levosimendan on diaphragm function in mechanically ventilated patients.
Approved WMOPending
Number of patients with >=80% reduction of VT burden, i.e., any ICD-treated or highly-symptomatic VT episodes, at one year after STAR compared to the year before (including VTs during the 8 week-blanking period). Efficacy parameters will be…
Approved WMOPending
To assess safety and performance of the LithiX Coronary HCIVLC to treat moderately to severely calcified coronary artery lesions by calcium fragmentation utilizing Hertzian contact stress from LithiX HCIVLC.